Related Experiment Videos
Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
Mariko Morishita1, Kaoru Uchimaru, Katsuaki Sato
1Department of Advanced Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Tokyo 108-8639, Japan. morishi-@za2.so-net.ne.jp
International Journal of Molecular Medicine
|December 5, 2003
Summary
Dendritic cells (DCs) pulsed with human thyroglobulin (hTg) can activate T cells for thyroid cancer immunotherapy. This approach enhances immune responses to hTg, suggesting potential for effective cancer therapy.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Thyroglobulin (Tg) is a tumor-associated antigen in thyroid cancer.
- Enhancing immune responses to self-antigens like Tg for immunotherapy is challenging.
- Human peripheral blood monocyte-derived dendritic cells (DCs) are key antigen-presenting cells.
Purpose of the Study:
- To investigate if human Tg (hTg)-pulsed dendritic cells (DCs) can activate hTg-specific T cells.
- To determine the optimal DC subset for inducing T cell responses against hTg.
- To explore the potential of hTg-pulsed DCs in thyroid cancer immunotherapy.
Main Methods:
- Immature DCs (iDCs) and mature DCs (mDCs) were generated from human peripheral blood monocytes.
- DCs were pulsed with human thyroglobulin (hTg).
- The endocytic capacity of iDCs and mDCs for hTg was assessed.
- T cell activation and cytokine production (IFN-gamma) in response to hTg-pulsed DCs were measured.
Main Results:
- Immature DCs showed higher endocytosis of hTg compared to mature DCs.
- hTg-primed T cells exhibited a stronger response to hTg-pulsed mature DCs.
- hTg-pulsed mature DCs selectively induced interferon-gamma (IFN-gamma)-secreting T cells.
Conclusions:
- Human thyroglobulin-pulsed mature dendritic cells effectively enhance T cell responses.
- This strategy holds promise for potentiating immunotherapy in thyroid cancer.
- Vaccination with hTg-pulsed DCs may be a viable approach for thyroid cancer treatment.